UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024064
Receipt number R000027708
Scientific Title Safety and efficacy of 3% diquafosol ophthalmic solution for soft contact lens-related dry eye.
Date of disclosure of the study information 2016/09/16
Last modified on 2023/10/19 16:55:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Safety and efficacy of 3% diquafosol ophthalmic solution for soft contact lens-related dry eye.

Acronym

Safety and efficacy of diquafosol ophthalmic solution for soft contact lens-related dry eye.

Scientific Title

Safety and efficacy of 3% diquafosol ophthalmic solution for soft contact lens-related dry eye.

Scientific Title:Acronym

Safety and efficacy of diquafosol ophthalmic solution for soft contact lens-related dry eye.

Region

Japan


Condition

Condition

Dry eye

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy and safety of 3% diquafosol ophthalmic solution for soft contact lens-related dry eye.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Safety
Tear breakup time
corneal and conjunctival staining
subjective symptoms
contrast sensitivity

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Diquafosol Ophthalmic Solution 3%

Interventions/Control_2

Artificial tears

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

To have dry eye subjective symptoms in both eye
mean Tear break up time is less than 5 sec. or Schirmer I test is less than 5 mm (both eye)
To have corneal and conjunctival staining (both eye)

Key exclusion criteria

Patients have administration of eye drops for dry eye or steroid eye drops 14 days before start day of this study.
Patient with an infection eye disease.
Patient has a complication of an eye disease except dry eye. This complication is feared to discourage from evaluation of this study.
Patients with allergy to the ingredients used in the present study.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Masayo
Middle name
Last name Hashimoto

Organization

Santen Pharmaceutical Co., Ltd.

Division name

Japan Medical Affairs Group, Development Management Department, Japan Business

Zip code

530-8552

Address

4-20, Ofukacho, Kita-ku, Osaka

TEL

06-4802-9337

Email

clinical@santen.co.jp


Public contact

Name of contact person

1st name Yoshiaki
Middle name
Last name Yamada

Organization

Santen Pharmaceutical Co., Ltd

Division name

Japan Medical Affairs Group, Development Management Department, Japan Business

Zip code

530-8552

Address

4-20, Ofukacho, Kita-ku, Osaka

TEL

06-4802-9604

Homepage URL


Email

clinical@santen.co.jp


Sponsor or person

Institute

Santen Pharmaceutical Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Santen Pharmaceutical Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ibaraki Seinan Medical Center Hospital Ethical Review Board

Address

2190, Sakaimachi, Sashima, Ibaraki

Tel

0280-87-8111

Email

shomu@seinan-mch.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

茨城西南医療センター病院/Ibaraki Seinan Medical Center Hospital
土浦協同病院なめがた地域医療センター/Tsuchiura Kyodo General Hospital Namegata District Medical Center


Other administrative information

Date of disclosure of the study information

2016 Year 09 Month 16 Day


Related information

URL releasing protocol

None

Publication of results

Published


Result

URL related to results and publications

https://link.springer.com/article/10.1007/s12325-021-01910-8

Number of participants that the trial has enrolled

26

Results

Refer to paper

Results date posted

2023 Year 09 Month 29 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2021 Year 09 Month 29 Day

Baseline Characteristics

Refer to paper

Participant flow

Refer to paper

Adverse events

The following adverse events were observed in this study.

Pollen allergy (both eyes)
Sinusitis

Outcome measures

Corneal staining Score
Conjunctival staining score
Tear film breakup time
Tear volume
Subjective symptoms
Visual acuity
Contrast sensitivity

Plan to share IPD

The data presented in this study are available on request from the corresponding author.

IPD sharing Plan description

The data presented in this study are available on request from the corresponding author.


Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 05 Month 23 Day

Date of IRB

2016 Year 06 Month 09 Day

Anticipated trial start date

2016 Year 09 Month 07 Day

Last follow-up date

2017 Year 05 Month 10 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 09 Month 15 Day

Last modified on

2023 Year 10 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027708


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name